Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
基本信息
- 批准号:10411472
- 负责人:
- 金额:$ 36.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated Regions3-DimensionalAdaptor Signaling ProteinAddressApoptosisApplications GrantsAutomobile DrivingBasement membraneBindingBinding ProteinsCell LineCell SurvivalCellsCodeComplexCytoplasmDataDermalDiseaseEpidermisFamilyGene ExpressionGenerationsGenesGenetic TranscriptionGrowthHumanImmuneLeadMAP Kinase GeneMalignant NeoplasmsMediatingMelanoma CellMessenger RNAMitosisModelingMolecularMusMutationNatural regenerationNeoplasmsNormal tissue morphologyNuclear Pore ComplexOncogenicOutputPathway interactionsProcessProteinsRNARegulationReportingResearch DesignRoleSignal TransductionSkinSpecificitySquamous cell carcinomaTranscriptTranslatingTumor stageTumor-DerivedVEGFC genecancer diagnosiscell motilityclinically relevantcrosslinking and immunoprecipitation sequencingdesignexperimental studyhuman modelin vivoinsightknock-downloss of functionmRNA Exportmemberneoplasticnew technologyoverexpressionpluripotencyprogramsprotein complexstemtherapeutic targettherapy developmenttranscription factortumortumor initiationtumor progressiontumorigenesis
项目摘要
Project Summary/Abstract
Background: Cancer originates from genetic alterations that lead to changes in gene
expression programs that promote tumor survival, growth, motility and inhibits
differentiation and apoptosis. The mRNAs from this oncogenic gene expression program
must be exported to the cytoplasm to be translated into protein in order to promote
tumorigenesis. Whether there is regulation of export of tumor specific mRNAs and the
potential proteins involved in this process is unknown. We have shown that tumor
specific NXF1 adaptor proteins regulate export of oncogenic mRNAs. The adaptor
proteins are also highly upregulated during tumor initiation and knockdown of specific
adaptors inhibit tumorigenesis.
Objective/hypothesis: This proposal seeks to understand the molecular mechanisms
driving the progression from normal to neoplastic skin using a RAS driven human
epidermal tumor model. Our preliminary data suggests that 4 adaptor proteins are highly
upregulated during tumor initiation that associates with NXF1 to mediate the export of
the oncogenic gene expression program. Our objective is to characterize the role of
each tumor induced NXF1 adaptor protein in the progression of normal to neoplastic
skin. Furthermore we seek to determine the specific transcripts that each adaptor protein
binds during tumor initiation to promote tumorigenesis.
Specific Aims: (1) To determine the role of NXF1 adaptor proteins in the progression
from normal to neoplastic skin and (2) to identify the transcripts associated with NXF1
adaptor proteins and determine which bound transcripts are exported.
Study Design: To study epidermal tumorigenesis in a more clinically relevant setting,
we generate 3-dimensionally intact human skin, containing human epidermal cells (that
have been permanently knocked down for adaptor proteins) in the context of human
dermal stroma and basement membrane, regenerated on immune compromised mice.
By using this model, we can perform loss of function experiments on NXF1 adaptor
proteins in regenerated human skin to characterize their role in epidermal growth,
differentiation, and progression to neoplasia. We will use CLIP-Seq to determine the
RNAs associated with each adaptor protein during the progression from normal to
neoplastic epidermis.
项目摘要/摘要
背景:癌症来自导致基因变化的遗传改变
促进肿瘤生存,生长,运动和抑制的表达程序
分化和凋亡。该致癌基因表达程序的mRNA
必须将其导出到细胞质中才能翻译成蛋白质,以促进
肿瘤发生。是否有调节肿瘤特异性mRNA和
参与此过程的潜在蛋白质尚不清楚。我们已经表明肿瘤
特定的NXF1适配器蛋白调节致癌mRNA的出口。适配器
蛋白质在肿瘤开始期间也高度上调和敲低特异性
适配器抑制肿瘤发生。
客观/假设:该提议旨在理解分子机制
使用RAS驱动的人来推动从正常到肿瘤皮肤的进展
表皮肿瘤模型。我们的初步数据表明4种适配器蛋白高度高
在肿瘤开始期间与NXF1相关的肿瘤开始上调
致癌基因表达程序。我们的目标是表征
每个肿瘤在正常到肿瘤的进展中诱导NXF1衔接蛋白
皮肤。此外,我们试图确定每个衔接蛋白的特定转录本
结合肿瘤起源以促进肿瘤发生。
具体目的:(1)确定NXF1适配器蛋白在进展中的作用
从正常到肿瘤皮肤和(2)识别与NXF1相关的转录本
适配器蛋白并确定输出哪些结合的转录本。
研究设计:在更临床相关的环境中研究表皮肿瘤发生,
我们产生3维完整的人皮,其中包含人类表皮细胞(
在人类的背景下,已永久击倒适配器蛋白
皮肤基质和基底膜,在免疫受损小鼠上再生。
通过使用此模型,我们可以在NXF1适配器上执行功能实验的丢失
再生的人皮中的蛋白质以表征其在表皮生长中的作用,
分化和向肿瘤的发展。我们将使用夹式来确定
从正常到
肿瘤表皮。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE L SEN其他文献
GEORGE L SEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE L SEN', 18)}}的其他基金
Regulation of epidermal growth and differentiation through mRNA export
通过 mRNA 输出调节表皮生长和分化
- 批准号:
10675700 - 财政年份:2022
- 资助金额:
$ 36.14万 - 项目类别:
Regulation of Human Tumorigensis by Cancer Specific NXF1 Adaptor Proteins
癌症特异性 NXF1 接头蛋白对人类肿瘤发生的调节
- 批准号:
10596156 - 财政年份:2022
- 资助金额:
$ 36.14万 - 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
- 批准号:
10161730 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
- 批准号:
9916713 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
- 批准号:
10532171 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Post-Transcriptional Regulators of Epidermal Homeostasis and Neoplasia
表皮稳态和肿瘤的转录后调节因子
- 批准号:
10402316 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
- 批准号:
10053717 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Regulation of Human Epidermal Tumorigenesis by the mRNA Degradation Pathway
mRNA 降解途径调控人表皮肿瘤发生
- 批准号:
10304861 - 财政年份:2018
- 资助金额:
$ 36.14万 - 项目类别:
Limbal Stem Cell Fate and Corneal Specific Enhancers
角膜缘干细胞命运和角膜特异性增强剂
- 批准号:
9039606 - 财政年份:2015
- 资助金额:
$ 36.14万 - 项目类别:
Regulators of epidermal growth and differentiation
表皮生长和分化的调节剂
- 批准号:
10294731 - 财政年份:2015
- 资助金额:
$ 36.14万 - 项目类别:
相似海外基金
Role of miR-195 in Chemo-Resistant Ovarian Cancer
miR-195 在化疗耐药性卵巢癌中的作用
- 批准号:
10640540 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Mechanisms of viral RNA maturation by co-opting cellular exonucleases
通过选择细胞核酸外切酶使病毒 RNA 成熟的机制
- 批准号:
10814079 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
R21 MPI microRNA 定向疗法治疗早期胰腺癌
- 批准号:
10577609 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
Engineering detours around the biologic barriers to allogeneic, iPSC-derived CAR T immunotherapy
工程绕开了同种异体、iPSC 衍生的 CAR T 免疫疗法的生物障碍
- 批准号:
10607952 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 36.14万 - 项目类别: